Chemed (NYSE:CHE) Director Andrea Lindell Sells 1,347 Shares

Chemed Corporation (NYSE:CHE) Director Andrea Lindell sold 1,347 shares of Chemed stock in a transaction on Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total transaction of $602,553.51. Following the completion of the sale, the director owned 4,578 shares of the company’s stock, valued at $2,047,876.74. This represents a 22.73% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Chemed Trading Down 2.1%

Shares of NYSE:CHE traded down $9.45 during mid-day trading on Wednesday, hitting $436.81. The company had a trading volume of 109,263 shares, compared to its average volume of 230,180. The firm has a fifty day moving average price of $412.34 and a 200 day moving average price of $424.66. The company has a market capitalization of $5.80 billion, a PE ratio of 23.80, a price-to-earnings-growth ratio of 1.65 and a beta of 0.54. The company has a debt-to-equity ratio of 0.11, a current ratio of 0.85 and a quick ratio of 0.83. Chemed Corporation has a one year low of $365.20 and a one year high of $562.77.

Chemed (NYSE:CHE) last released its quarterly earnings data on Thursday, April 23rd. The company reported $5.65 earnings per share for the quarter, beating the consensus estimate of $5.30 by $0.35. The company had revenue of $657.51 million during the quarter, compared to analyst estimates of $659.22 million. Chemed had a net margin of 10.23% and a return on equity of 27.18%. Chemed’s revenue for the quarter was up 1.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $5.63 EPS. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. As a group, research analysts forecast that Chemed Corporation will post 22.3 EPS for the current year.

Chemed Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 16th. Shareholders of record on Thursday, May 28th will be paid a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date is Thursday, May 28th. Chemed’s payout ratio is 13.08%.

Institutional Trading of Chemed

Institutional investors have recently made changes to their positions in the company. Monetary Solutions Ltd bought a new stake in shares of Chemed in the 4th quarter worth $25,000. Los Angeles Capital Management LLC bought a new stake in shares of Chemed in the 4th quarter worth $26,000. Smartleaf Asset Management LLC grew its stake in shares of Chemed by 71.4% in the 3rd quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock worth $27,000 after acquiring an additional 25 shares in the last quarter. BOK Financial Private Wealth Inc. bought a new stake in shares of Chemed in the 4th quarter worth $27,000. Finally, Global Retirement Partners LLC grew its stake in shares of Chemed by 200.0% in the 4th quarter. Global Retirement Partners LLC now owns 87 shares of the company’s stock worth $37,000 after acquiring an additional 58 shares in the last quarter. Institutional investors own 95.85% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have commented on CHE. Wall Street Zen lowered shares of Chemed from a “buy” rating to a “hold” rating in a research note on Monday. Oppenheimer decreased their price target on shares of Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a research note on Friday, February 27th. Zacks Research upgraded shares of Chemed from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. Weiss Ratings upgraded shares of Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, April 29th. Finally, Royal Bank Of Canada boosted their price target on shares of Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a research note on Monday, April 27th. Two analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $501.50.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.